Apraglutide: "Average 50% reduction in PS volume and 47% reduction in energy content by 6 months in the first 5 patients"; Short bowel syndrome colon-in-continuity (VectivBio) - Oct 29, 2022 - STARS Nutrition-Interim Data Summary: "Greater than 30% average PS reduction in all 9 patients by 3 months"
P2 data • Short Bowel Syndrome
|